Insulet Corp (PODD)
164.65
-0.08
(-0.05%)
USD |
NASDAQ |
Apr 19, 15:26
Insulet Gross Profit Margin (Quarterly): 70.85% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.85% |
| September 30, 2023 | 67.78% |
| June 30, 2023 | 66.81% |
| March 31, 2023 | 67.16% |
| December 31, 2022 | 58.78% |
| September 30, 2022 | 55.25% |
| June 30, 2022 | 63.56% |
| March 31, 2022 | 70.99% |
| December 31, 2021 | 69.29% |
| September 30, 2021 | 68.47% |
| June 30, 2021 | 69.41% |
| March 31, 2021 | 66.39% |
| December 31, 2020 | 65.46% |
| September 30, 2020 | 64.87% |
| June 30, 2020 | 62.97% |
| March 31, 2020 | 64.09% |
| December 31, 2019 | 64.04% |
| September 30, 2019 | 64.08% |
| June 30, 2019 | 65.73% |
| March 31, 2019 | 66.85% |
| December 31, 2018 | 66.92% |
| September 30, 2018 | 67.50% |
| June 30, 2018 | 66.05% |
| March 31, 2018 | 61.35% |
| December 31, 2017 | 60.92% |
| Date | Value |
|---|---|
| September 30, 2017 | 60.46% |
| June 30, 2017 | 58.89% |
| March 31, 2017 | 58.40% |
| December 31, 2016 | 58.83% |
| September 30, 2016 | 58.65% |
| June 30, 2016 | 57.78% |
| March 31, 2016 | 54.24% |
| December 31, 2015 | 50.11% |
| September 30, 2015 | 44.22% |
| June 30, 2015 | 50.40% |
| March 31, 2015 | 60.63% |
| December 31, 2014 | |
| September 30, 2014 | 50.73% |
| June 30, 2014 | 49.66% |
| March 31, 2014 | 47.44% |
| December 31, 2013 | 48.18% |
| September 30, 2013 | 44.83% |
| June 30, 2013 | 44.65% |
| March 31, 2013 | 43.86% |
| December 31, 2012 | 43.78% |
| September 30, 2012 | 44.55% |
| June 30, 2012 | 43.76% |
| March 31, 2012 | 42.50% |
| December 31, 2011 | 42.55% |
| September 30, 2011 | 41.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
55.25%
Minimum
Sep 2022
70.99%
Maximum
Mar 2022
65.58%
Average
65.73%
Median
Jun 2019
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 55.51% |
| Stryker Corp | 63.68% |
| Becton Dickinson & Co | 43.07% |
| Haemonetics Corp | 52.90% |
| Tandem Diabetes Care Inc | 47.41% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 35.90% |
| Return on Assets | 8.61% |
| Return on Invested Capital | 10.41% |
| Profit Margin (Quarterly) | 20.26% |
| Operating Margin (Quarterly) | 20.87% |
| Return on Net Operating Assets | 13.42% |